Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emily Greengard
COG Phase I Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Columbia University/herbert Irving Cancer Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Baylor College of Medicine/dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Apr 2013
- Primary completion
- 31 Dec 2018
- Completion
- 31 Dec 2018
- Last update posted
- 5 Jan 2024
- Registered enrollment
- 46
- Registry id
- NCT01606878
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.